Drugs / Branched-chain Amino Acid

Trials 4

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 32 trials
Phase 3 NCT06121492 Nov 2023 → Jun 2026 overdue cirrhosis of liver, muscular atrophy Mahidol University Enrolling by invitation No outcome recorded
Phase 3 NCT03633279 Jun 2018 → Jan 2024 overdue cirrhosis of liver Dayanand Medical College and Hospital Active not recruiting No outcome recorded
Phase 42 trials
Phase 4 NCT06538077 Feb 2025 → Aug 2026 overdue cirrhosis of liver, hepatic encephalopathy Post Graduate Institute of Medical Education and Research, Chandigarh Recruiting No outcome recorded
Phase 4 NCT02755701 Jul 2016 → Jun 2018 cirrhosis of liver Soonchunhyang University Hospital Unknown No outcome recorded
Comparator or background therapy1 trial
Phase 4 NCT05724485 Comparator Apr → Oct 2023 cirrhosis of liver Mahidol University Completed No outcome recorded

Evidence & citations 6 cited values

Every value below carries the sentence it was read from. 6 sources stand behind the page.

FieldValueCited text
Known as Branched-chain amino acid ClinicalTrials.gov intervention name — accepted as the source's own label NCT06121492 ↗
4

NCT02755701 ↗

NCT03633279 ↗

NCT06538077 ↗

NCT05724485 ↗

Known as BCAA “The active drug BCAA supplement will be dispensed in a dose of 15 gm once daily x 12 weeks” NCT06538077 ↗
Known as branched-chain amino acids “Branched-chain amino acids (BCAA) had been developed to correct this amino acid imbalance and helped to decrease the frequency of cramps and improve the quality of life in...” NCT05724485 ↗
Action Activate “The possible effect of Branched Chain Amino acids on sarcopenia is that leucine primarily activates the mammalian target of rapamycin signaling pathway involved in muscle...” NCT03633279 ↗
Modality Other / unclassified “Branched-chain amino acids (BCAAs) are a group of essential amino acids comprising valine, leucine, and isoleucine.” PMID 21563202 ↗ Jun 2011
Route Oral “12.45 grams of BCAA orally per day before bedtime” NCT05724485 ↗